Skip to content

PRIMA-CNS: Optimization of patient-oriented trial information looking at needs and concerns regarding tretament decisions of elderly patients withy Primary CNS-Lymphoma

PRIMA-CNS: Optimization of patient-oriented trial information looking at needs and concerns regarding tretament decisions of elderly patients withy Primary CNS-Lymphoma - PRIMA-CNS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022068
Enrollment
20
Registered
2021-03-17
Start date
2020-09-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C83.3

Interventions

Group 1: Through qualitative interviews elderly patients with CNS lymphoma or their relatives will be asked for their patient needs, information needs, experiences, wishes, concerns and fears regardin

Sponsors

UNIVERSITÄTSKLINIKUM FREIBURGTumorzentrum / CCC FreiburgStiftungsprofessur Selbsthilfeforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: Immunocompetent patients with PCNSL, Age > 65 years, Histological or cytological assessed diagnosis of PCNSL, Ability to read and understand German, Willingsness and ability to give informed consent before study entry, Patient's written informed consent has been obtained

Exclusion criteria

Exclusion criteria: No written consent available

Design outcomes

Primary

MeasureTime frame
Through qualitative interviews elderly patients with CNS lymphoma or their relatives will be asked for their patient needs, information needs, experiences, wishes, concerns and fears regarding their study information process. The interview willl be based on a semi-structured interview guide line. Study participants must have already been through the study information process.

Secondary

MeasureTime frame
Patients will be asked to fill out questionnaires regarding anxiety (GAD-7) and despression (PHQ-9) after the interview.

Countries

Germany

Contacts

Public ContactElisabeth Schorb

Abteilung für Hämatologie, Onkologie und StammzelltransplantationUniversitätsklinikum Freiburg

elisabeth.schorb@uniklinik-freiburg.de+49-761-270-35360

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026